Prudential Financial’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-36,191
| Closed | -$2.45M | – | 2522 |
|
|
2019
Q3 | $2.45M | Sell |
36,191
-36,587
| -50% | -$2.51M | ﹤0.01% | 1490 |
|
|
2019
Q2 | $4.23M | Sell |
72,778
-161,867
| -69% | -$9.59M | 0.01% | 1227 |
|
|
2019
Q1 | $16.4M | Sell |
234,645
-50,423
| -18% | -$3.74M | 0.03% | 623 |
|
|
2018
Q4 | $18.4M | Sell |
285,068
-79,363
| -22% | -$5.56M | 0.03% | 563 |
|
|
2018
Q3 | $25.6M | Buy |
364,431
+65,556
| +22% | +$3.83M | 0.04% | 528 |
|
|
2018
Q2 | $15.1M | Buy |
298,875
+96,712
| +48% | +$3.84M | 0.02% | 762 |
|
|
2018
Q1 | $6.33M | Sell |
202,163
-2,714
| -1% | -$90K | 0.01% | 1080 |
|
|
2017
Q4 | $7.01M | Buy |
204,877
+26,867
| +15% | +$857K | 0.01% | 1020 |
|
|
2017
Q3 | $5.71M | Sell |
178,010
-6,060
| -3% | -$191K | 0.01% | 1091 |
|
|
2017
Q2 | $5.99M | Sell |
184,070
-11,670
| -6% | -$370K | 0.01% | 1068 |
|
|
2017
Q1 | $6.16M | Sell |
195,740
-1,750
| -0.9% | -$51.8K | 0.01% | 1032 |
|
|
2016
Q4 | $5.8M | Buy |
197,490
+13,400
| +7% | +$409K | 0.01% | 1048 |
|
|
2016
Q3 | $5.32M | Buy |
184,090
+98,160
| +114% | +$2.73M | 0.01% | 1042 |
|
|
2016
Q2 | $2.23M | Buy |
85,930
+43,000
| +100% | +$1.14M | ﹤0.01% | 1509 |
|
|
2016
Q1 | $1.06M | Buy |
42,930
+23,900
| +126% | +$656K | ﹤0.01% | 1790 |
|
|
2015
Q4 | $670K | Sell |
19,030
-4,600
| -19% | -$123K | ﹤0.01% | 1917 |
|
|
2015
Q3 | $500K | Buy |
23,630
+100
| +0.4% | +$2.58K | ﹤0.01% | 1943 |
|
|
2015
Q2 | $654K | Buy |
23,530
+500
| +2% | +$14.1K | ﹤0.01% | 1917 |
|
|
2015
Q1 | $704K | Buy |
23,030
+700
| +3% | +$22.3K | ﹤0.01% | 1919 |
|
|
2014
Q4 | $714K | Buy |
22,330
+1,100
| +5% | +$35.8K | ﹤0.01% | 1849 |
|
|
2014
Q3 | $601K | Sell |
21,230
-3,420
| -14% | -$95.4K | ﹤0.01% | 1875 |
|
|
2014
Q2 | $675K | Buy |
24,650
+3,320
| +16% | +$88.4K | ﹤0.01% | 1933 |
|
|
2014
Q1 | $562K | Sell |
21,330
-300
| -1% | -$8.61K | ﹤0.01% | 1920 |
|
|
2013
Q4 | $633K | Sell |
21,630
-100
| -0.5% | -$3.17K | ﹤0.01% | 1908 |
|
|
2013
Q3 | $665K | Sell |
21,730
-3,700
| -15% | -$124K | ﹤0.01% | 1867 |
|
|
2013
Q2 | $806K | Buy |
+25,430
| New | +$835K | ﹤0.01% | 1799 |
|
Prudential Financial's GHDX Position: Q4 2019 in Review
Prudential Financial sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 36,191 shares — an estimated $2.45M sold.
Prudential Financial first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $25.6M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Prudential Financial reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Prudential Financial sold 36,191 Genomic Health, Inc. shares in Q4 2019, an estimated $2.45M.
- Prudential Financial first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Prudential Financial's Genomic Health, Inc. position peaked at $25.6M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Prudential Financial's 13F filing for Q4 2019, filed 11 Feb 2020.